Navigation Links
The Medical Affairs Company Expands Its Medical Communications Division
Date:2/23/2009

ATLANTA, Feb. 23 /PRNewswire/ -- The Medical Affairs Company LLC (TMAC(R)), the leading provider of outsourced medical science liaison (MSL) services, announced today a significant expansion of its medical communications division.

In response to an increasing client demand for clinician-staffed, project-based medical information and medical meeting surveillance services, TMAC has recently expanded the size of its Medical Communications division to better meet these needs. This expansion strengthens TMAC's ability to provide the pharmaceutical, biotechnology and medical device industries with a complete array of outsourcing capabilities for medical affairs activities.

    TMAC's Medical Communications capabilities include the provision of:

    -- Inbound and Outbound Medical Information Services
    -- Adverse Event (AE) and Product Complaint (PC) handling
    -- Medical Writing including standard letter, FAQ, SOP development
    -- Literature Surveillance and Summarization, including Pharmacovigilance
    -- Medical Meeting Surveillance and Support

"Expanding our core medical affairs offering to include clinician-staffed, highly customized Medical Communications services considerably enhances our Contract Medical Organization (CMO) model," states Dr. Evan Demestihas, TMAC's CEO. He adds, "Importantly, this expansion provides our clients with strategic, flexible and cost-efficient options. In today's economic environment, clients want to be assured that they are spending their budgets wisely and using their resources efficiently. TMAC's flexible offerings allow clients to better utilize their internal resources to focus on their current priorities, while we focus on implementing their medical affairs strategies with expertly trained healthcare professionals."

About The Medical Affairs Company

The Medical Affairs Company LLC (TMAC(R)) is a full service Contract Medical Organization that provides pharmaceutical, biotechnology, and medical device industry clients a wide array of outsourcing capabilities for medical affairs activities. Providing both strategic and tactical medical science liaison support services in addition to medical science liaison consulting and medical communications support, TMAC is uniquely positioned to provide both unmatched value and service to the pharmaceutical industry. TMAC's greatest strength is their focus: medical and scientific affairs - it is their only business.

Please visit TMAC's website at: TheMedicalAffairsCompany.com.


'/>"/>
SOURCE The Medical Affairs Company LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eurofins announces the appointment of Sean Murray ... Scientific Inc. (ESI). Mr. Murray will bring valuable ... entrepreneurial experience in leading international business teams. As the National Division ... to uphold Eurofins, status as the global leader in bio-analytical testing ... , , ...
(Date:12/8/2016)... 8, 2016  Anaconda BioMed S.L., a pre-clinical stage ... next generation neuro-thrombectomy system for the treatment of Acute ... Jovin, MD to join its Scientific Advisory Board (SAB). ... network of scientific and clinical experts to Anaconda BioMed ... ANCD BRAIN ® to its clinical phase. The ...
(Date:12/8/2016)... PRINCETON, N.J. , Dec. 8, 2016 /PRNewswire/ ... a late-stage biopharmaceutical company focused on developing and ... is an unmet medical need, announced today the ... trial with SGX942 (dusquetide), a first-in-class Innate Defense ... (OM) in head and neck cancer patients undergoing ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security (DHS) issued ... the Biometric Exit Program. The Request for Information (RFI), ... that CBP intends to add biometrics to confirm when ... , in order to deter visa overstays, to ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
Breaking Biology News(10 mins):